These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5450047)

  • 1. [Amantadine for parkinsonism].
    Flatberg P
    Tidsskr Nor Laegeforen; 1970 May; 90(10):1101-2. PubMed ID: 5450047
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa and amantadine in the therapy of parkinsonism.
    Weeth JB; Shealy CN; Mercier DA
    Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-time therapy of Parkinsonism with amantadine sulfate. Reply to L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsonism"].
    Fünfgeld EW
    Munch Med Wochenschr; 1972 Jun; 114(22):1064-5. PubMed ID: 5068021
    [No Abstract]   [Full Text] [Related]  

  • 4. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 5. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amantadine and dexetimide in the treatment of parkinsonism].
    Hakkarainen H; Viukari M
    Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nil nocere. Adverse effects of amantadine therapy of parkinsonism. Summary to E.W. Fünfgeld: "Long-time therapy of parkinsonism with amantadine sulfate" and to G. Völler: "Amantadine therapy of parkinsonism"].
    Diehl LW
    Munch Med Wochenschr; 1972 Jun; 114(22):1068. PubMed ID: 5068023
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
    Man'kovskii NB; Vainshtok AB; Oleinik LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amantadine treatment in parkinsonism].
    Holmsen R
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984
    [No Abstract]   [Full Text] [Related]  

  • 10. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
    Appleton DB; Eadie MJ; Sutherland JM
    Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term therapy of parkinsonism using amantadine salts].
    Damielczyk W; Struppler A; Velho-Groneberg P; Clemens R; Diehl LW
    Med Welt; 1976 Apr; 27(14):669-75. PubMed ID: 1263820
    [No Abstract]   [Full Text] [Related]  

  • 12. [Amantadine in the treatment of Parkinson's disease].
    Giombini S; Solero CL; Bazzan A; Ferrari P; Robotti E
    Fracastoro; 1970; 63(6):869-81. PubMed ID: 5519639
    [No Abstract]   [Full Text] [Related]  

  • 13. [Principles for amantadine therapy in parkinsonism].
    Gilland O
    Lakartidningen; 1972 Nov; 69(46):5343-5. PubMed ID: 4650743
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amantadine. Prolonged clinical trial in 50 parkinsonian patients].
    Castaigne P; Laplane D; Dordain G
    Nouv Presse Med; 1972 Feb; 1(8):533-6. PubMed ID: 5012351
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of parkinsonism with viregyt (amantadine)].
    Pryszmont M; Jankowicz E; Eljasz L; Slizewski M; Wiśniewska Z
    Wiad Lek; 1974 Aug; 27(15):1371-5. PubMed ID: 4418066
    [No Abstract]   [Full Text] [Related]  

  • 16. The continued use of amantadine hydrochloride in parkinsonism.
    Appleton DB; Eadie MJ; Sutherland JM
    Med J Aust; 1971 Oct; 2(14):707-9. PubMed ID: 4939890
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
    N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 19. [Note on the treatment of parkinsonism with amantadine].
    Serratrice G
    Mars Med; 1971; 108(3):241-2. PubMed ID: 5576122
    [No Abstract]   [Full Text] [Related]  

  • 20. Amantadine therapy in parkinsonism.
    Forssman B; Kihlstrand S; Larsson LE
    Acta Neurol Scand; 1972; 48(1):1-18. PubMed ID: 4553409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.